Profile data is unavailable for this security.
About the company
PerkinElmer, Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The Company provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its products under various brand names, including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, Datalytix, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROline, EUROPattern, FragilEase, Genoglyphix, GSP, and others.
- Revenue in USD (TTM)5.02bn
- Net income in USD674.23m
- Incorporated1947
- Employees16.70k
- LocationPerkinElmer Inc940 Winter StreetWALTHAM 02451United StatesUSA
- Phone+1 (781) 663-5776
- Websitehttps://www.perkinelmer.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Integra Lifesciences Holdings Corp | 1.57bn | 166.30m | 4.59bn | 3.80k | 28.03 | 2.76 | 16.02 | 2.93 | 1.96 | 1.96 | 18.48 | 19.89 | 0.4198 | 1.77 | 6.45 | 412,325.80 | 4.46 | 3.26 | 4.85 | 3.61 | 63.58 | 64.21 | 10.61 | 7.36 | 2.76 | 6.87 | 0.4825 | 0.00 | 12.43 | 9.23 | 26.28 | 17.79 | 0.3158 | -- |
| MKS Instruments, Inc. | 3.01bn | 555.60m | 6.17bn | 6.00k | 11.11 | 1.97 | 9.25 | 2.05 | 9.97 | 9.97 | 54.04 | 56.18 | 0.6727 | 2.69 | 6.57 | 502,133.30 | 12.40 | 11.30 | 13.75 | 12.58 | 45.64 | 45.93 | 18.44 | 15.91 | 3.63 | 29.71 | 0.2066 | 12.14 | 26.59 | 17.89 | 57.50 | 39.38 | 35.30 | 4.81 |
| Cognex Corporation | 1.09bn | 258.67m | 7.97bn | 2.26k | 31.64 | 5.74 | 28.65 | 7.34 | 1.45 | 1.45 | 6.11 | 8.02 | 0.5474 | 3.79 | 6.69 | 481,146.70 | 13.04 | 15.17 | 14.49 | 16.40 | 71.29 | 74.27 | 23.82 | 28.48 | 3.32 | -- | 0.00 | 44.87 | 27.88 | 14.39 | 58.86 | 14.22 | 3.82 | 10.68 |
| Bruker Corporation | 2.48bn | 273.90m | 8.94bn | 7.77k | 33.46 | 9.22 | 24.53 | 3.61 | 1.80 | 1.80 | 16.33 | 6.54 | 0.7651 | 1.64 | 6.69 | 318,840.90 | 8.53 | 7.68 | 11.83 | 10.50 | 50.74 | 47.94 | 11.14 | 9.57 | 1.62 | 25.47 | 0.5447 | 12.96 | 21.66 | 8.46 | 75.60 | 12.53 | 19.92 | 0.00 |
| Bio Rad Laboratories Inc | 2.87bn | -1.94bn | 15.41bn | 7.90k | -- | 1.73 | -- | 5.37 | -66.32 | -66.32 | 95.80 | 300.45 | 0.2066 | 1.96 | 6.76 | 363,415.10 | -13.97 | 24.42 | -14.61 | 26.36 | 57.05 | 55.45 | -67.66 | 83.24 | 4.22 | 0.1668 | 0.1183 | 0.00 | 14.81 | 7.16 | 11.55 | 177.08 | -3.10 | -- |
| Avantor Inc | 7.60bn | 572.10m | 18.78bn | 13.50k | 31.65 | 4.20 | 19.15 | 2.47 | 0.8803 | 0.8803 | 11.79 | 6.63 | 0.6161 | 5.67 | 5.99 | 563,170.40 | 5.09 | -- | 5.79 | -- | 34.21 | 32.51 | 8.27 | 2.42 | 1.05 | 4.66 | 0.594 | -- | 15.52 | 60.60 | 876.92 | -- | 30.02 | -- |
| PerkinElmer, Inc. | 5.02bn | 674.23m | 19.11bn | 16.70k | 27.92 | 2.67 | 16.97 | 3.81 | 5.43 | 5.42 | 40.57 | 56.82 | 0.4379 | 4.03 | 5.22 | 300,600.00 | 5.88 | 6.63 | 6.49 | 7.70 | 54.31 | 52.31 | 13.43 | 14.32 | 1.42 | 8.13 | 0.3851 | 6.55 | 33.95 | 19.09 | 29.55 | 34.32 | 25.80 | 0.00 |
| Waters Corporation | 2.90bn | 702.12m | 19.39bn | 7.80k | 28.22 | 49.54 | 23.18 | 6.68 | 11.47 | 11.47 | 47.41 | 6.54 | 0.9442 | 3.20 | 4.91 | 371,868.30 | 22.85 | 16.20 | 29.77 | 19.44 | 58.11 | 58.48 | 24.21 | 24.16 | 1.55 | 24.15 | 0.791 | 0.00 | 17.78 | 5.15 | 32.84 | 5.85 | 12.12 | -- |
| Fortive Corp | 5.52bn | 658.60m | 23.10bn | 18.00k | 35.82 | 2.45 | 21.09 | 4.19 | 1.81 | 1.80 | 15.18 | 26.56 | 0.3609 | 4.54 | 6.27 | 306,422.20 | 4.31 | 5.23 | 5.19 | 6.41 | 57.39 | 55.00 | 11.94 | 15.08 | 0.7267 | 9.60 | 0.2804 | 14.06 | 13.38 | -0.4635 | -58.09 | -4.77 | -14.60 | 14.87 |
| AMETEK, Inc. | 5.92bn | 1.09bn | 28.66bn | 18.50k | 26.54 | 4.12 | 20.45 | 4.84 | 4.70 | 4.70 | 25.44 | 30.27 | 0.4985 | 4.61 | 6.50 | 319,865.00 | 9.22 | 8.84 | 10.80 | 10.20 | 34.62 | 36.20 | 18.49 | 16.73 | 0.8849 | 17.51 | 0.2647 | 16.88 | 22.17 | 7.63 | 13.48 | 14.09 | 11.83 | 17.32 |
| Keysight Technologies Inc | 5.14bn | 1.02bn | 29.24bn | 14.50k | 29.40 | 7.74 | 23.28 | 5.69 | 5.53 | 5.53 | 27.79 | 21.01 | 0.6655 | 2.34 | 6.95 | 359,510.50 | 13.24 | 7.68 | 15.98 | 9.25 | 63.96 | 58.17 | 19.90 | 11.73 | 2.26 | 16.64 | 0.3217 | 0.00 | 17.06 | 11.11 | 42.58 | 21.69 | 13.84 | -- |
| Mettler-Toledo International Inc. | 3.87bn | 820.63m | 29.59bn | 15.60k | 37.04 | 4,074.34 | 31.73 | 7.65 | 35.49 | 35.49 | 167.19 | 0.3227 | 1.19 | 3.96 | 6.30 | 247,779.90 | 25.33 | 21.43 | 37.11 | 30.07 | 58.32 | 58.00 | 21.23 | 18.72 | 0.7701 | 22.37 | 0.9963 | 0.00 | 20.51 | 8.19 | 27.58 | 14.88 | -2.79 | -- |
| Illumina, Inc. | 4.66bn | 700.00m | 33.75bn | 9.80k | 46.85 | 3.10 | 33.95 | 7.25 | 4.58 | 4.58 | 30.23 | 69.39 | 0.3875 | 3.50 | 8.12 | 475,102.00 | 5.83 | 10.93 | 6.58 | 12.96 | 68.81 | 68.81 | 15.03 | 23.16 | 1.54 | -- | 0.1377 | 0.00 | 39.73 | 13.54 | 16.16 | 10.49 | -5.15 | -- |
Data as of Aug 10 2022. Currency figures normalised to PerkinElmer Inc's reporting currency: US Dollar USD
56.90%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2022 | 14.95m | 11.85% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2022 | 14.32m | 11.35% |
| The Vanguard Group, Inc.as of 31 Mar 2022 | 13.23m | 10.49% |
| BlackRock Fund Advisorsas of 31 Mar 2022 | 6.16m | 4.88% |
| Select Equity Group LPas of 31 Mar 2022 | 5.73m | 4.54% |
| SSgA Funds Management, Inc.as of 31 Mar 2022 | 5.16m | 4.09% |
| Massachusetts Financial Services Co.as of 31 Mar 2022 | 4.18m | 3.31% |
| Pictet Asset Management SAas of 31 Mar 2022 | 3.54m | 2.81% |
| Geode Capital Management LLCas of 31 Mar 2022 | 2.43m | 1.93% |
| Janus Henderson Investors US LLCas of 31 Mar 2022 | 2.09m | 1.65% |
More ▼
Data from 31 Mar 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
